Lotus Medical Devices India Limi Ted Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 18-07-2024
- Paid Up Capital ₹ 3.90 M
as on 18-07-2024
- Company Age 21 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 66.67%
(FY 2022)
- Profit 29.55%
(FY 2022)
- Ebitda -705.84%
(FY 2022)
- Net Worth -0.97%
(FY 2022)
- Total Assets 3.27%
(FY 2022)
About Lotus Medical Devices India Limi Ted
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.90 M, as per Ministry of Corporate Affairs (MCA) records.
Anjum Afshan, Ana Rehmani, Sanjeev Gupta, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110UP2003PTC027906
- Company No.
027906
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Sep 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Yashoda Nagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Lotus Medical Devices India Limi Ted?
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Anjum Afshan | Director | 22-Sep-2003 | Current |
Ana Rehmani | Director | 02-Nov-2020 | Current |
Sanjeev Gupta | Additional Director | 31-Mar-2023 | Current |
Rina Gupta | Additional Director | 31-Mar-2023 | Current |
Financial Performance of Lotus Medical Devices India Limi Ted.
Lotus Medical Devices India Private Limi Ted, for the financial year ended 2022, experienced significant growth in revenue, with a 66.67% increase. The company also saw a substantial improvement in profitability, with a 29.55% increase in profit. The company's net worth dipped by a decrease of 0.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Lotus Medical Devices India Limi Ted?
In 2021, Lotus Medical Devices India Limi Ted had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Descon Buildtech Private LimitedActive 16 years 11 months
Sanjeev Gupta and Rina Gupta are mutual person
- Maya Builders Private LimitedActive 36 years 2 months
Anjum Afshan and Ana Rehmani are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lotus Medical Devices India Limi Ted?
Unlock and access historical data on people associated with Lotus Medical Devices India Limi Ted, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lotus Medical Devices India Limi Ted, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lotus Medical Devices India Limi Ted's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.